EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY-NC 3.0

An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects

Yang Li, Yue Liu, Megumi Iwai, Masato Takeuchi, Nan Song, Yuan Li, Aixin Shi iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s486562 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijin…. Hauptthemen laut MEDLINE: Heterocyclic Compounds, 2-Ring, Thiadiazoles. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heterocyclic Compounds, 2-RingThiadiazolesAdolescentAdultFemaleHumansMiddle AgedYoung AdultAdministration, OralAsian PeopleChinaCross-Over StudiesDose-Response Relationship, DrugHealthy Volunteers

Stichwörter der Autor:innen

menopauseneurokinin receptornonhormonalvasomotor symptoms

Substanzen

fezolinetantHeterocyclic Compounds, 2-RingThiadiazoles

Autor:innen und Institutionen

  • Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Astellas Pharma Inc, Tokyo, Japan.
  • Astellas (China) Investment Co, Ltd, Beijing, People's Republic of China.

ORCID-Profile: Aixin Shi

Zitieren

APA

Li, Y., Liu, Y., Iwai, M., Takeuchi, M., Song, N., Li, Y., & Shi, A. (2025). An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s486562

Vancouver

Li Y, Liu Y, Iwai M, Takeuchi M, Song N, Li Y, et al. An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s486562

BibTeX
@article{Li2025,
  author = {Li, Yang and Liu, Yue and Iwai, Megumi and Takeuchi, Masato and Song, Nan and Li, Yuan and Shi, Aixin},
  title = {An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s486562}
}
Kostenlos starten →